TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
UroMedical PS AB
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
45,255
|
40,203
|
35,206 |
Financial expenses |
60
|
32
|
5 |
Earnings before taxes |
16,455
|
18,970
|
16,816 |
EBITDA |
15,555
|
16,037
|
14,096 |
Total assets |
73,361
|
65,905
|
48,458 |
Current assets |
73,181
|
65,541
|
47,408 |
Current liabilities |
23,139
|
17,217
|
4,885 |
Equity capital |
47,263
|
45,531
|
40,104 |
- share capital |
101
|
95
|
98 |
Employees (average) |
12
![]() |
12
|
11 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
64.4%
|
69.1%
|
82.8% |
Turnover per employee |
3,771
|
3,350
|
3,201 |
Profit as a percentage of turnover |
36.4%
|
47.2%
|
47.8% |
Return on assets (ROA) |
22.5%
|
28.8%
|
34.7% |
Current ratio |
316.3%
|
380.7%
|
970.5% |
Return on equity (ROE) |
34.8%
|
41.7%
|
41.9% |
Change turnover |
2,199
|
6,056
|
13,742 |
Change turnover % |
5%
|
18%
|
64% |
Chg. No. of employees |
0
|
1
|
-2 |
Chg. No. of employees % |
0%
|
9%
|
-15% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.